TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Scanbio Ingredients AS
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
919,064
|
1,138,307
|
793,560 |
| Financial expenses |
274,887
|
254,049
|
117,295 |
| Earnings before taxes |
66,207
|
108,568
|
112,160 |
| Total assets |
904,255
|
686,844
|
568,353 |
| Current assets |
699,251
|
519,990
|
435,584 |
| Current liabilities |
566,463
|
321,712
|
195,731 |
| Equity capital |
332,329
|
360,662
|
371,886 |
| - share capital |
230,777
|
234,938
|
251,609 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
36.8%
|
52.5%
|
65.4% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
7.2%
|
9.5%
|
14.1% |
| Return on assets (ROA) |
37.7%
|
52.8%
|
40.4% |
| Current ratio |
123.4%
|
161.6%
|
222.5% |
| Return on equity (ROE) |
19.9%
|
30.1%
|
30.2% |
| Change turnover |
-199,082
|
397,325
|
135,219 |
| Change turnover % |
-18%
|
54%
|
21% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.